马拉松跑步中容量调节与体温调节在急性肾损伤中的作用
该前瞻性队列研究纳入2017年哈特福德马拉松23名跑者,评估容量与体温调节对急性肾损伤(AKI)的影响。汗液钠和容量丢失及血浆和肽素水平与AKI相关。
要点
- 汗液容量丢失(P=0.03)和血浆和肽素升高(P=0.02)与AKI显著相关。
- 汗液钠丢失在AKI组更高但差异未达统计学意义(P=0.06)。
核心结论
- 马拉松跑者普遍出现和肽素和体温升高,伴随出汗导致的盐和水丢失。
- 经汗液丢失的钠和容量以及血浆和肽素浓度与AKI相关。
研究设计与样本
- 前瞻性队列研究,纳入2017年哈特福德马拉松23名跑者,年龄22-63岁,43%为男性。
- 赛前1天、赛后即刻和赛后1天收集生命体征、血液和尿液样本,比赛中监测核心体温、汗钠和容量。
- 主要结局为按AKIN标准定义的AKI。
主要发现
- 跑者经汗液丢失钠中位数2.34(范围0.50-7.21)g,容量中位数2.47(范围0.36-6.81)L,扣除摄入后净钠和容量负平衡。
- 多数跑者核心体温升至38.4(范围35.8-41)°C。
- AKI组汗钠丢失中位数3.41(IQR 1.7-4.8)g vs 非AKI组1.4(IQR 0.97-2.8)g,P=0.06;汗容量丢失中位数3.89(IQR 1.49-5.09)L vs 1.66(IQR 0.72-2.84)L,P=0.03。
- AKI组血浆和肽素中位数79.9(IQR 25.2-104.4)vs 非AKI组11.3(IQR 6.6-43.7),P=0.02;估计体温无显著差异。
关键数值与推荐
- AKI定义采用AKIN标准。
- 跑步经验更丰富和既往马拉松参赛次数更多的跑者肌酐升高更明显。
临床怎么用
- 对于马拉松跑者,应关注出汗导致的容量和钠丢失,及时补充可能有助于预防AKI。
- 血浆和肽素可作为反映容量应激和AKI风险的潜在指标。
局限性
- 样本量较小(23人),可能影响统计效能。
- 汗钠丢失与AKI的关联未达到统计学显著性(P=0.06)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Marathon runners develop transient AKI with urine sediments and injury biomarkers suggesting nephron damage. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: To investigate the etiology, we examined volume and thermoregulatory responses as possible mechanisms in runners' AKI using a prospective cohort of runners in the 2017 Hartford Marathon. Vitals, blood, and urine samples were collected in 23 runners 1 day premarathon and immediately and 1 day postmarathon. We measured copeptin at each time point. Continuous core body temperature, sweat sodium, and volume were assessed during the race. The primary outcome of interest was AKI, defined by AKIN criteria. RESULTS: Runners ranged from 22 to 63 years old; 43% were men. Runners lost a median (range) of 2.34 (0.50-7.21) g of sodium and 2.47 (0.36-6.81) L of volume via sweat. After accounting for intake, they had a net negative sodium and volume balance at the end of the race. The majority of runners had increases in core body temperature to 38.4 (35.8-41)°C during the race from their baseline. Fifty-five percent of runners developed AKI, yet 74% had positive urine microscopy for acute tubular injury. Runners with more running experience and increased participation in prior marathons developed a rise in creatinine as compared with those with lesser experience. Sweat sodium losses were higher in runners with AKI versus non-AKI (median, 3.41 [interquartile range (IQR), 1.7-4.8] versus median, 1.4 [IQR, 0.97-2.8] g; P=0.06, respectively). Sweat volume losses were higher in runners with AKI versus non-AKI (median, 3.89 [IQR, 1.49-5.09] versus median, 1.66 [IQR, 0.72-2.84] L; P=0.03, respectively). Copeptin was significantly higher in runners with AKI versus those without (median, 79.9 [IQR, 25.2-104.4] versus median, 11.3 [IQR, 6.6-43.7]; P=0.02, respectively). Estimated temperature was not significantly different. CONCLUSIONS: All runners experienced a substantial rise in copeptin and body temperature along with salt and water loss due to sweating. Sodium and volume loss via sweat as well as plasma copeptin concentrations were associated with AKI in runners. PODCAST: This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2019_08_13_CJASNPodcast_19_09_.mp3.
引用
- Mansour SG, Martin TG, Obeid W, et al. The Role of Volume Regulation and Thermoregulation in AKI during Marathon Running. Clin J Am Soc Nephrol. 2019. PMID: 31413064. doi:10.2215/CJN.01400219
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。